CIMA_METMA
ID CIMA_METMA Reviewed; 483 AA.
AC P58966;
DT 02-AUG-2002, integrated into UniProtKB/Swiss-Prot.
DT 02-AUG-2002, sequence version 1.
DT 03-AUG-2022, entry version 118.
DE RecName: Full=Putative (R)-citramalate synthase CimA {ECO:0000255|HAMAP-Rule:MF_01028};
DE EC=2.3.1.182 {ECO:0000255|HAMAP-Rule:MF_01028};
GN Name=cimA {ECO:0000255|HAMAP-Rule:MF_01028}; OrderedLocusNames=MM_0671;
OS Methanosarcina mazei (strain ATCC BAA-159 / DSM 3647 / Goe1 / Go1 / JCM
OS 11833 / OCM 88) (Methanosarcina frisia).
OC Archaea; Euryarchaeota; Stenosarchaea group; Methanomicrobia;
OC Methanosarcinales; Methanosarcinaceae; Methanosarcina.
OX NCBI_TaxID=192952;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC BAA-159 / DSM 3647 / Goe1 / Go1 / JCM 11833 / OCM 88;
RX PubMed=12125824;
RA Deppenmeier U., Johann A., Hartsch T., Merkl R., Schmitz R.A.,
RA Martinez-Arias R., Henne A., Wiezer A., Baeumer S., Jacobi C.,
RA Brueggemann H., Lienard T., Christmann A., Boemecke M., Steckel S.,
RA Bhattacharyya A., Lykidis A., Overbeek R., Klenk H.-P., Gunsalus R.P.,
RA Fritz H.-J., Gottschalk G.;
RT "The genome of Methanosarcina mazei: evidence for lateral gene transfer
RT between Bacteria and Archaea.";
RL J. Mol. Microbiol. Biotechnol. 4:453-461(2002).
CC -!- FUNCTION: Catalyzes the condensation of pyruvate and acetyl-coenzyme A
CC to form (R)-citramalate. {ECO:0000255|HAMAP-Rule:MF_01028}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=acetyl-CoA + H2O + pyruvate = (3R)-citramalate + CoA + H(+);
CC Xref=Rhea:RHEA:19045, ChEBI:CHEBI:15361, ChEBI:CHEBI:15377,
CC ChEBI:CHEBI:15378, ChEBI:CHEBI:30934, ChEBI:CHEBI:57287,
CC ChEBI:CHEBI:57288; EC=2.3.1.182; Evidence={ECO:0000255|HAMAP-
CC Rule:MF_01028};
CC -!- PATHWAY: Amino-acid biosynthesis; L-isoleucine biosynthesis; 2-
CC oxobutanoate from pyruvate: step 1/3. {ECO:0000255|HAMAP-
CC Rule:MF_01028}.
CC -!- SUBUNIT: Homodimer. {ECO:0000255|HAMAP-Rule:MF_01028}.
CC -!- SIMILARITY: Belongs to the alpha-IPM synthase/homocitrate synthase
CC family. {ECO:0000255|HAMAP-Rule:MF_01028}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AE008384; AAM30367.1; -; Genomic_DNA.
DR AlphaFoldDB; P58966; -.
DR SMR; P58966; -.
DR STRING; 192952.MM_0671; -.
DR EnsemblBacteria; AAM30367; AAM30367; MM_0671.
DR KEGG; mma:MM_0671; -.
DR PATRIC; fig|192952.21.peg.797; -.
DR eggNOG; arCOG02092; Archaea.
DR HOGENOM; CLU_022158_0_1_2; -.
DR OMA; SNMFAHE; -.
DR UniPathway; UPA00047; UER00066.
DR Proteomes; UP000000595; Chromosome.
DR GO; GO:0043714; F:(R)-citramalate synthase activity; IEA:UniProtKB-EC.
DR GO; GO:0003852; F:2-isopropylmalate synthase activity; IEA:InterPro.
DR GO; GO:0009097; P:isoleucine biosynthetic process; IEA:UniProtKB-UniRule.
DR GO; GO:0009098; P:leucine biosynthetic process; IEA:InterPro.
DR Gene3D; 3.20.20.70; -; 1.
DR Gene3D; 3.30.160.270; -; 1.
DR HAMAP; MF_01028; CimA; 1.
DR InterPro; IPR013709; 2-isopropylmalate_synth_dimer.
DR InterPro; IPR002034; AIPM/Hcit_synth_CS.
DR InterPro; IPR013785; Aldolase_TIM.
DR InterPro; IPR024890; Citramalate_synthase_CimA.
DR InterPro; IPR011830; LEU1_arch.
DR InterPro; IPR036230; LeuA_allosteric_dom_sf.
DR InterPro; IPR000891; PYR_CT.
DR Pfam; PF00682; HMGL-like; 1.
DR Pfam; PF08502; LeuA_dimer; 1.
DR SMART; SM00917; LeuA_dimer; 1.
DR SUPFAM; SSF110921; SSF110921; 1.
DR TIGRFAMs; TIGR02090; LEU1_arch; 1.
DR PROSITE; PS00816; AIPM_HOMOCIT_SYNTH_2; 1.
DR PROSITE; PS50991; PYR_CT; 1.
PE 3: Inferred from homology;
KW Amino-acid biosynthesis; Branched-chain amino acid biosynthesis;
KW Isoleucine biosynthesis; Reference proteome; Transferase.
FT CHAIN 1..483
FT /note="Putative (R)-citramalate synthase CimA"
FT /id="PRO_0000140452"
FT DOMAIN 1..245
FT /note="Pyruvate carboxyltransferase"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01151"
SQ SEQUENCE 483 AA; 52040 MW; F930741357CE86C9 CRC64;
MRDGEQTPGV ALTKEKKLLI ARALDEMKIN VIEAGSAITS AGERESVRAV ANAGLSAEIC
SYCRIVKTDV DHALECDVDS IHLVVPVSDL HIRTKIKKDR DTVRQIAADV TEYAKEHGLI
VELSGEDSSR ADLGFLKAVY SDGIDAGADR LCFCDTVGLL VPEKTTEIFR DLSSSLKAPI
SIHCHNDFGL ATANTVAALA AGAKQAHVTI NGLGERAGNA SLEEVVMCLE WLYKYDTGIK
HEQIYRTSRL VSRLTGIPVS PNKALVGGNA FTHEAGIHVH GLLADKATYE PMSPEYIGRQ
RQIVLGKHAG RSSITLALKE MGLEADDAQT EEIFNRVKQM GDQGKHVTDA DLQIIAETVL
DIYKEPLVKL EEFTIVSGNR VTPTASIKLN VKDKEIVQAG IGNGPVDAVI NAIRRAVSSC
AEDVILEEYH VDAVTGGTDA LVEVRVKLSK EGKSITASGA RTDIIMASVE AVMNGLNRLV
RAE